Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Scope & Guideline

Empowering breakthroughs in diagnosis and assessment.

Introduction

Delve into the academic richness of Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherWILEY
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationALZH DEMENT-DADM / Alzheimers Dement.-Diagn. Assess. Dis. Monit.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring' focuses on advancing knowledge related to Alzheimer's disease and other dementias through rigorous research methodologies. It emphasizes the importance of innovative diagnostic techniques, assessment tools, and monitoring strategies that can improve clinical outcomes and enhance the quality of life for individuals affected by these conditions.
  1. Multimodal Biomarkers and Diagnostic Techniques:
    Research involving cerebrospinal fluid (CSF), blood-based biomarkers, neuroimaging, and genetic factors to improve the diagnosis and understanding of Alzheimer's disease pathology.
  2. Cognitive Assessment and Monitoring Tools:
    Development and validation of cognitive assessment tools, including digital and remote testing methods, aimed at early detection and monitoring of cognitive decline.
  3. Neuropsychiatric Symptoms and Behavioral Factors:
    Exploration of the relationship between neuropsychiatric symptoms, behavioral changes, and cognitive impairment in dementia patients.
  4. Lifestyle and Environmental Influences:
    Studies examining the impact of lifestyle factors, such as physical activity, diet, and socioeconomic status, on cognitive health and dementia risk.
  5. Health Disparities and Ethnic Variability:
    Research addressing the differences in dementia prevalence, risk factors, and outcomes across diverse populations, focusing on health equity and access to care.
  6. Technological Innovations in Research:
    Utilization of machine learning, artificial intelligence, and digital health technologies for improving diagnostic precision and understanding of cognitive decline.
Recent publications in the journal indicate several emerging themes that reflect current trends and innovations in dementia research. These themes point to a more nuanced understanding of Alzheimer's disease and related disorders.
  1. AI and Machine Learning Applications:
    There is a rising trend in utilizing AI and machine learning techniques to analyze cognitive decline, identify biomarkers, and improve diagnostic accuracy.
  2. Integration of Lifestyle Factors:
    An increasing number of studies are focusing on how lifestyle factors, such as nutrition, physical activity, and social engagement, influence cognitive health and dementia risk.
  3. Biomarker Discovery and Validation:
    Research on novel biomarkers, particularly blood-based and neuroimaging biomarkers, is gaining traction as a means to enhance early detection and monitoring of Alzheimer's disease.
  4. Cultural and Social Determinants of Health:
    A growing interest in understanding how cultural and social determinants influence dementia prevalence and outcomes, particularly in diverse populations, is evident in recent publications.
  5. Digital Health Interventions:
    Emerging interest in digital tools and remote monitoring technologies for assessing cognitive function and delivering interventions, especially in the context of the COVID-19 pandemic.
  6. Comorbidity and Multimorbidity Research:
    Research exploring the interactions between Alzheimer's disease and other chronic conditions, highlighting the complexity of patient care and the need for integrated health strategies.

Declining or Waning

In recent years, certain themes within the journal's scope have shown a decline in focus, reflecting shifts in research priorities and emerging interests. The following areas appear to be waning in prominence based on the recent publication trends.
  1. Traditional Cognitive Assessment Methods:
    There has been a noticeable decrease in studies solely focused on conventional cognitive assessments, as the field moves towards more innovative and diverse methods of evaluation.
  2. Single-Factor Risk Assessments:
    Research that examines isolated risk factors for dementia without considering the multimodal interactions has become less common, with a growing emphasis on comprehensive, integrative approaches.
  3. Aging without Cognitive Decline Focus:
    Studies that exclusively investigate aging without a direct connection to cognitive decline or dementia have diminished, as the focus shifts towards understanding the cognitive trajectories related to aging.
  4. Generalized Dementia Studies:
    Research that does not differentiate between types of dementia (e.g., Alzheimer’s versus Lewy body dementia) is less frequent, as there is a growing recognition of the need for subtype-specific investigations.

Similar Journals

BEHAVIOURAL NEUROLOGY

Connecting Dots: Unraveling the Complexities of Mind and Brain
Publisher: HINDAWI LTDISSN: 0953-4180Frequency: 1 issue/year

BEHAVIOURAL NEUROLOGY is a distinguished open-access journal published by Hindawi Ltd, dedicated to advancing the field of neurology and neuropsychology since its inception in 1988. With ISSN: 0953-4180 and E-ISSN: 1875-8584, this journal provides a platform for innovative research and interdisciplinary studies that explore the intricate connections between behavior and neurological processes. Housed in the Netherlands, BEHAVIOURAL NEUROLOGY enjoys a commendable reputation, boasting impressive quartile rankings of Q2 in various medical and psychological categories, reflecting its significant contribution to the literature with a focus on clinical neurology and physiological psychology. The journal's rigorous peer-review process ensures that published works meet high academic standards, making it an essential resource for researchers, clinicians, and students seeking to deepen their understanding of neurological disorders and cognitive function. As of 2023, it ranks in the 80th percentile in neuropsychology, further underscoring its impact and relevance in the scientific community. For those interested in accessible knowledge, BEHAVIOURAL NEUROLOGY's commitment to open access facilitates the dissemination of groundbreaking research, allowing a wider audience to engage with critical advancements in the field.

Translational Neurodegeneration

Driving Breakthroughs in Neurodegenerative Disease Treatment
Publisher: BMCISSN: 2047-9158Frequency: 1 issue/year

Translational Neurodegeneration, an esteemed journal in the field of neuroscience, is published by BMC and has been an open access platform since 2012, delivering high-quality research from its base in the United Kingdom. With an impressive impact factor reflecting its significant contributions, this journal focuses on critical advancements in cellular and molecular neuroscience, cognitive neuroscience, and clinical neurology, boasting a Q1 ranking across all these categories as of 2023. Researchers and professionals benefit from its extensive reach, characterized by exceptional Scopus rankings that place it in the top percentile of its field. The journal serves as a vital resource for academics and healthcare practitioners alike, aiming to bridge the gap between laboratory discoveries and clinical applications, thereby enhancing understanding and treatment of neurodegenerative diseases. With its commitment to open access, Translational Neurodegeneration ensures that its published research is accessible to a global audience, promoting collaboration and knowledge exchange within the scientific community.

Alzheimers & Dementia-Translational Research & Clinical Interventions

Innovating Tomorrow's Treatments for Alzheimer's Today
Publisher: WILEYISSN: Frequency: 1 issue/year

Alzheimer's & Dementia: Translational Research & Clinical Interventions, published by WILEY, is a premier open-access journal that has been at the forefront of innovations in the field of neurology and psychiatry since its inception in 2015. With an impressive impact factor reflecting its high-quality research contributions, this journal has been designated as Q1 in both Neurology (Clinical) and Psychiatry and Mental Health categories for 2023, ranking in the top percentiles of their respective Scopus fields. The journal aims to bridge the gap between research and clinical practice, promoting the translation of scientific discoveries into real-world applications for Alzheimer's disease and other dementias. Positioned in the United States, it is a valuable resource for researchers, clinicians, and students dedicated to advancing knowledge and treatment approaches in these critical areas. With its commitment to open access, the journal ensures that vital research is accessible to a broad audience, fostering collaboration and knowledge sharing across the global scientific community.

Frontiers in Aging Neuroscience

Unlocking Insights into Cognitive Aging.
Publisher: FRONTIERS MEDIA SAISSN: 1663-4365Frequency: 1 issue/year

Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.

Psychogeriatrics

Empowering professionals with cutting-edge psychogeriatric research.
Publisher: WILEYISSN: 1346-3500Frequency: 4 issues/year

Psychogeriatrics is a leading peer-reviewed journal published by WILEY, dedicated to advancing the understanding of mental health and geriatric psychiatry. With an ISSN of 1346-3500 and an E-ISSN of 1479-8301, this journal has been integral to the field since its inception in 2005 and continues to publish cutting-edge research until 2024. Recognized for its impact, Psychogeriatrics holds a commendable Q2 quartile ranking in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health as of 2023. The journal's Scopus rankings reflect its significant contribution to Nursing Gerontology, Medicine Psychiatry and Mental Health, and Medicine Geriatrics and Gerontology. Although it operates with no open access options, Psychogeriatrics remains a vital resource for researchers, professionals, and students who are exploring the complexities of mental health in older populations. The journal not only disseminates innovative research but also tackles pressing issues related to the psychological well-being of the elderly, making it essential reading for anyone focused on improving geriatric mental health care.

JOURNAL OF ALZHEIMERS DISEASE

Illuminating the path to better cognitive health.
Publisher: IOS PRESSISSN: 1387-2877Frequency: 24 issues/year

Journal of Alzheimer's Disease, published by IOS Press, stands as a pivotal resource in the fight against Alzheimer's and related neurodegenerative disorders. With an ISSN of 1387-2877 and an E-ISSN of 1875-8908, this esteemed journal has evolved since its inception in 1998, providing a vital platform for academic research and clinical practice in the realms of Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Ranked in the Q1 category across several disciplines, including Clinical Psychology and Geriatrics, this journal not only highlights significant advancements in understanding Alzheimer's disease but also fosters interdisciplinary dialogue among researchers, healthcare professionals, and policymakers. Boasting robust Scopus rankings—such as 49th in Clinical Psychology and 29th in Geriatrics—this journal is committed to disseminating high-quality research that informs both therapeutic strategies and public health initiatives. The Journal of Alzheimer's Disease is an essential resource for anyone dedicated to exploring the complexities of cognitive decline and enhancing care for affected individuals.

JPAD-Journal of Prevention of Alzheimers Disease

Exploring Breakthroughs in Neurology and Mental Health
Publisher: SPRINGER BASEL AGISSN: 2274-5807Frequency: 4 issues/year

JPAD - Journal of Prevention of Alzheimer’s Disease, published by Springer Basel AG, is a premier academic journal dedicated to advancing research in the critical field of Alzheimer’s disease prevention. Its impactful contributions to the fields of neurology, psychiatry, and mental health have led it to achieve a Q1 ranking in multiple categories, including neurology (clinical) and psychiatry and mental health. Since its inception in 2017, JPAD has become an essential platform for researchers and professionals aiming to stay at the forefront of developments in Alzheimer’s disease research, prevention strategies, and innovative therapies. The journal provides a valuable open access option for disseminating high-quality research to a global audience, enhancing its visibility and impact. With its strategic focus and rigorous peer-review process, JPAD is committed to fostering collaboration and knowledge exchange among scientists, clinicians, and practitioners, ultimately contributing to the global effort to combat Alzheimer's disease.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Advancing knowledge in cognitive health for aging minds.
Publisher: KARGERISSN: 1420-8008Frequency: 6 issues/year

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.

Applied Neuropsychology-Adult

Illuminating the path of neuropsychological advancements.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 2327-9095Frequency: 6 issues/year

Applied Neuropsychology-Adult is a premier journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to advancing the field of neuropsychology with a particular focus on adult populations. Since its inception in 2012, this journal has been a vital platform for disseminating innovative research, reviews, and clinical insights into the cognitive and psychological processes that influence adult behavior and functioning. With an impressive Scopus ranking, including Q3 status in both Developmental and Educational Psychology and Neuropsychology and Physiological Psychology, it demonstrates a commitment to high-quality scholarship that informs both clinical practice and theoretical understanding. Researchers, clinicians, and students alike will benefit from the journal's commitment to open access, providing broad access to valuable knowledge in the domain of neuropsychology. As it converges towards its 2024 milestone, Applied Neuropsychology-Adult continues to be an essential resource for those seeking to deepen their understanding of neuropsychological processes and their application in real-world settings.

Alzheimers & Dementia

Advancing the frontiers of dementia research.
Publisher: WILEYISSN: 1552-5260Frequency: 12 issues/year

Alzheimers & Dementia is a premier journal published by WILEY that focuses on the latest advancements in understanding, diagnosing, and treating Alzheimer's disease and other dementias. With an ISSN of 1552-5260 and an E-ISSN of 1552-5279, this influential journal boasts a commendable impact factor and ranks in the Q1 category across several disciplines, including *Cellular and Molecular Neuroscience*, *Geriatrics and Gerontology*, and *Neurology (Clinical)*. By publishing cutting-edge research, systematic reviews, and innovative clinical trials, Alzheimers & Dementia aims to bridge the gap between basic neuroscience and clinical practice, offering valuable insights into the etiology, epidemiology, and management of dementia-related disorders. The journal is hosted in the United States and operates under a balanced access model, providing essential resources for researchers, healthcare professionals, and students dedicated to tackling the challenges posed by these neurodegenerative diseases. Available online, it plays a pivotal role in shaping current and future research directions in the vibrant field of dementia studies.